InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,567.19
(
1.06%
)
US TECH 100
19,828.00
(
0.95%
)
Dow Jones
39,375.87
(
0.17%
)
Brent Oil
86.78
(
0.00%
)
Bitcoin
56,817.03
(
-2.55%
)
Post# of 252501
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Whalatane

Send PM Follow Ignore
Followers 120
Posts 20756
Boards Moderated 0
Alias Born 06/13/2011

Whalatane

Member Level

Re: semi_infinite post# 217654

Monday, 03/05/2018 3:16:42 PM

Monday, March 05, 2018 3:16:42 PM

Post# of 252501
MYOK ...Nowlurking ...Paradigm -HF was an Outcome trial .. Entresto is a combination drug ( Sacubitril / Valsartan ). I do not know the history of Sacubitril but Valsartan was approved in 2002 .

The MYOK trial you referred to is designed with FDA input and accepted by them . There will be a long term safety follow up for this trial . Its not an Outcome trial .

I intend to stay long into the March 10th ACC data presentation .
Kiwi
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up